Nature
Gene Therapy
(ISSN 1476-5462)
Aims and scope
Gene Therapy covers both the research and clinical applications of novel therapeutic techniques based on a genetic component. Over the last few decades, significant advances in technologies ranging from identifying novel genetic targets that cause disease through to clinical studies, which show therapeutic benefit, have elevated this multidisciplinary field to the forefront of modern medicine.
Gene Therapy covers all aspects of gene therapy as applied to human disease, including:
preliminary studies which reveal novel genetic targets or strategies that improve a disease phenotype (Note: studies showing the mechanistic role of genetic elements alone, will be considered if significant therapeutic benefit or novelty is shown)
the development of novel techniques for gene therapy research and improvements on established tools
preclinical animal model systems and validation studies
gene-based vaccine development and applications
genetically engineered cellular models that can advance the validation of novel therapeutic targets, and drug discovery especially those using high-throughput applications and 3D modelling
cell-based therapies including all aspects of stem cells and genetically modified cellular approaches (especially CRISPR and other gene editing strategies), including biobanking studies
clinical trial reports which have significant impact for the field
novel genetic biomarkers of disease susceptibility or disease progression with extensive scientific validation
Industry sector pipeline profiles or commercial implications of gene therapies
Regulatory landscapes and legislative issues pertaining to different global regions
Gene Therapy covers a range of subject areas, to read content across the scope of the journal view the journal's subjects page here.
Journal Metrics
Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.
The 2021 journal metrics for Gene Therapy are as follows:
2-year Impact Factor* (2021): 4.184
5-year Impact Factor* (2021): 4.527
Immediacy index*: 1.532
Eigenfactor® score*: 0.00336
Article influence score*: 0.951
JCR Rank*: 69/175 Genetics & Heredity; 150/296 Biochemistry & Molecular Biology; 63/158 Biotechnology & Applied Microbiology; 72/139 Medicine, Research & Experimental
Journal Citation Score*: 0.96
SNIP: 0.847
SJR: 1.332
The 2021 peer review performance metrics for Gene Therapy are shown below:
13 days to first decision for all manuscripts (Median)
Article page views - 852,378
Usage:
1,461,535 Downloads (in 2021)
4,402 Altmetric mentions (2021)
*2021 Journal Citation Reports® Science Edition (Clarivate Analytics, 2022)
Abstracted/indexed in
BIOSIS
Current Contents/Life Sciences
Science Citation Index
Science Citation Index Expanded (SciSearch)
EBSCO Discovery Service
Google Scholar
Medline
Social Science Citation Indes
SCOPUS
Summon by ProQuest
EBSCO Academic Search
EBSCO Advanced Placement Source
EBSCO Biomedical Reference Collection
EBSCO STM Source
EBSCO TOC Premier
ISSN and eISSN
International standard serial number (ISSN) for Gene Therapy: 0969-7128
Electronic international standard serial number (eISSN): 1476-5462.
News Feeds
Gene Therapy now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.
Receive Gene Therapy's current issue table of contents
Receive Gene Therapy's AOP table of contents.